WCM
LFCR icon

Wedge Capital Management’s Lifecore Biomedical LFCR Stock Holding History

Wedge Capital Management’s Portfolio LFCR Stock Details LFCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-72,000
Closed -$1.07M – 586
2018
Q2 		$1.07M Hold
72,000
– – 0.01% 346
2018
Q1 		$940K Hold
72,000
– – 0.01% 357
2017
Q4 		$907K Hold
72,000
– – 0.01% 372
2017
Q3 		$932K Hold
72,000
– – 0.01% 370
2017
Q2 		$1.07M Buy
72,000
+28,600
+66% +$398K 0.01% 331
2017
Q1 		$521K Hold
43,400
– – 0.01% 428
2016
Q4 		$599K Hold
43,400
– – 0.01% 408
2016
Q3 		$582K Hold
43,400
– – 0.01% 412
2016
Q2 		$467K Hold
43,400
– – ﹤0.01% 446
2016
Q1 		$456K Sell
43,400
-3,400
-7% -$37.3K ﹤0.01% 452
2015
Q4 		$554K Sell
46,800
-2,000
-4% -$24.6K 0.01% 431
2015
Q3 		$569K Hold
48,800
– – 0.01% 433
2015
Q2 		$704K Hold
48,800
– – 0.01% 376
2015
Q1 		$681K Hold
48,800
– – 0.01% 381
2014
Q4 		$674K Sell
48,800
-1,400
-3% -$18.1K 0.01% 396
2014
Q3 		$615K Sell
50,200
-4,800
-9% -$59.9K 0.01% 408
2014
Q2 		$687K Sell
55,000
-2,700
-5% -$31.8K 0.01% 366
2014
Q1 		$644K Buy
57,700
+4,700
+9% +$51.6K 0.01% 374
2013
Q4 		$642K Buy
53,000
+8,800
+20% +$105K 0.01% 360
2013
Q3 		$539K Buy
44,200
+8,100
+22% +$113K 0.01% 375
2013
Q2 		$477K Buy
+36,100
New +$499K 0.01% 377

Other funds holding LFCR

NIMC
NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
WC
Wynnefield Capital New York $148M AUM 32.71% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
WC
Walthausen & Co Malta, New York $120M AUM 2.66% 1-Year Est. Return
ICOM
Investment Counselors of Maryland Baltimore, Maryland $4.37B AUM 76.25% 1-Year Est. Return

Wedge Capital Management's LFCR Position: Q3 2018 in Review

Wedge Capital Management sold out of Lifecore Biomedical (LFCR) in Q3 2018, closing a stake of 72,000 shares — an estimated $1.07M sold.

Wedge Capital Management first reported a position in LFCR in Q2 2013 and held it in 21 quarters. The position peaked at $1.07M in Q2 2018. 90 funds tracked by Wall St. Rank hold LFCR as of Q3 2018.

  • Wedge Capital Management reported no remaining Lifecore Biomedical position as of Q3 2018 after selling out during the quarter.
  • Wedge Capital Management sold 72,000 Lifecore Biomedical shares in Q3 2018, an estimated $1.07M.
  • Wedge Capital Management first reported a position in Lifecore Biomedical in Q2 2013 and held it in 21 quarters.
  • Wedge Capital Management's Lifecore Biomedical position peaked at $1.07M in Q2 2018.
  • 90 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q3 2018.

Based on Wedge Capital Management's 13F filing for Q3 2018, filed 1 Nov 2018.